Dwojaka aktywnosc metforminu: areszt cyklu komorkwego i apoptoza zalezna od mitohondriow
wspominalem o nim takze tutaj:
Metformin - lek na cukrzyce typu II robi to samo co p53
DCA i metformin zmniejszają ilość guzów piersi u gryzoni
Ścieżka LKB1/AMPK-molek. powiązanie między cukrzycą a rakiem
przedruk z:
http://www.ncbi.nlm.nih.gov/pubmed/17447005
Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis.
Isakovic A, Harhaji L, Stevanovic D, Markovic Z, Sumarac-Dumanovic M, Starcevic V, Micic D, Trajkovic V.
Institute of Biochemistry, School of Medicine, University of Belgrade, Belgrade, Serbia.
The present study reports for the first time a dual antiglioma effect of the well-known antidiabetic drug metformin. In low-density cultures of the C6 rat glioma cell line, metformin blocked the cell cycle progression in G(0)/G(1) phase without inducing significant cell death. In confluent C6 cultures, on the other hand, metformin caused massive induction of caspase-dependent apoptosis associated with c-Jun N-terminal kinase (JNK) activation, mitochondrial depolarization and oxidative stress. Metformin-triggered apoptosis was completely prevented by agents that block mitochondrial permeability transition (cyclosporin A) and oxygen radical production (N-acetylcisteine), while the inhibitors of JNK activation (SP600125) or glycolysis (sodium fluoride, iodoacetate) provided partial protection. The antiglioma effect of metformin was reduced by compound C, an inhibitor of AMP-activated protein kinase (AMPK), and was mimicked by the AMPK agonist AICAR. Similar effects were observed in the human glioma cell line U251, while rat primary astrocytes were completely resistant to the antiproliferative and proapoptotic action of metformin.
PMID: 17447005 [PubMed - indexed for MEDLINE